Recent advances in the management of carcinoma of the rectum

References

• MilesWEA method of performing abdominoperineal excision for carcinoma of the rectum and the terminal portion of the pelvic colonCancer190821812
   Google Scholar
• HealdRJMoranBJRyallRDRectal cancer: The Basingstoke experience of total mesorectal excision, 1978–1997Arch Surg19981338948999711965
   PubMed Web of Science ®Google Scholar
• NelsonRLDollearTFreelsSPerskyVThe relation of age, race, and gender to the subsite location of colorectal carcinomaCancer1997801931979217029
   PubMed Web of Science ®Google Scholar
• EnkerWEKafkaNJMartzJPlanes of sharp pelvic dissection for primary, locally advanced, or recurrent rectal cancerSemin Surg Oncol20001819920610757885
   PubMedGoogle Scholar
• FearonERVogelsteinBA genetic model for colorectal carcinogenesisCell1990617597672188735
   PubMed Web of Science ®Google Scholar
• KatsuraYYamadaKIshizawaTEndorectal ultrasonography for the assessment of wall invasion and lymph node metastasis in rectal cancerDis Colon Rectum1992353623691582359
   PubMed Web of Science ®Google Scholar
• RifkinMDEhrlichSMMarksGStaging of rectal carcinoma: prospective comparison of endorectal US and CTRadiology19891703193222643135
   PubMed Web of Science ®Google Scholar
• OrromWJWongWDRothenbergerDAEndorectal ultrasound in the preoperative staging of rectal tumors: A learning experienceDis Colon Rectum1990336546592198147
   PubMed Web of Science ®Google Scholar
• BipatSGlasASSlorsFJZwindermanAHBossuytPMStokerJRectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging – a meta-analysisRadiology200423277378315273331
   PubMed Web of Science ®Google Scholar
• GuillemJGMooreHGAkhurstTSequential preoperative fluorodeoxyglucose positron emission tomography assessment of response to preoperative chemoradiation: A means for determining long-term outcomes of rectal cancerJ Am Coll Surg20041991715217621
   PubMed Web of Science ®Google Scholar
• KantorovaILipskaLBelohlavekOVisokaiVTrubacMSchneiderovaMRoutine (18) F-FDG PET preoperative staging of colorectal cancer; comparison with conventional staging and its impact on treatment decision makingJ Nucl Med2003441784178814602860
   PubMed Web of Science ®Google Scholar
• ChessinDBKiranRPAkhurstTGuillemJGThe emerging role of 18F fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancerJ Am Coll Surg2005194895616310700
   PubMed Web of Science ®Google Scholar
• AlbrechtTHohmannJOldenburgASkrokJWolfKJDetection and characterization of liver metastasesEur Radiol200414Suppl 8P25P3315700330
   PubMed Web of Science ®Google Scholar
• Van EttenBVan Der SijpJKruytROudkerkMvan der HoltBWiggersTFerumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastasesEur J Surg Oncol20022864565112359202
   PubMed Web of Science ®Google Scholar
• ContantCMHopWCvan’t SantHPMechanical bowel preparation for elective colorectal surgery: a multicenter randomized trialLancet200737096052112211718156032
   PubMed Web of Science ®Google Scholar
• BretagnolFAlvesARicciAValleurPPanisYRectal cancer surgery without mechanical bowel preparationBr J Surg200794101266127117657719
   PubMed Web of Science ®Google Scholar
• VlotEAZeebregtsCJGerritsenJJMulderHJMastboomWJKlaaseJMAnterior resection of rectal cancer without bowel preparation and diverting stomaSurg Today200535862963316034541
   PubMed Web of Science ®Google Scholar
• BasuSShuklaVKMechanical bowel preparation: are we ready for a paradigm shiftDig Surg20082532532818818500
   PubMed Web of Science ®Google Scholar
• WolmarkNFisherBAn analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes’ B and C rectal carcinoma: A report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel ProjectAnn Surg19862044804893532972
   PubMed Web of Science ®Google Scholar
• NelsonHPetrelliNCarlinAGuidelines 2000 for colon and rectal cancer surgeryJ Natl Cancer Inst20019358359611309435
   PubMed Web of Science ®Google Scholar
• NagtegaalIDQuirkePWhat is the role for the circumferential margin in the modern treatment of rectal cancer?J Clin Oncol20082630331218182672
   PubMed Web of Science ®Google Scholar
• HidaJYasutomiMMaruyamaTLymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: Justification of total mesorectal excisionJ Am Coll Surg19971845849179114
   PubMed Web of Science ®Google Scholar
• QuirkePDurdeyPDixonMFWilliamsNSLocal recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathology study of lateral tumor spread and surgical excisionLancet198629969992430152
   PubMed Web of Science ®Google Scholar
• HavengaKEnkerWEMcDermottKMale and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectumJ Am Coll Surg19961824955028646349
   PubMed Web of Science ®Google Scholar
• HealdRJRyallRDRecurrence and survival after total mesorectal excision for rectal cancerLancet19861147914822425199
   PubMed Web of Science ®Google Scholar
• KapiteijnEPutterHvan de VeldeCJCooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The NetherlandsBr J Surg2002891142114912190680
   PubMed Web of Science ®Google Scholar
• TepperJEO’ConnellMJNiedzwieckiDImpact of number of nodes retrieved on outcome in patients with rectal cancerJ Clin Oncol20011915716311134208
   PubMed Web of Science ®Google Scholar
• GrinnelRSResults of ligation of inferior mesenteric artery at the aorta in resections of carcinoma of the descending and sigmoid colon and rectumSurg Gynecol Obstet19651201031103614269834
   PubMedGoogle Scholar
• PezimMENichollsRJSurvival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancerAnn Surg19842007297336508403
   PubMed Web of Science ®Google Scholar
• MoriyaYHojoKSawadaTKoyamaYSignificance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflectionDis Colon Rectum1989323073152784376
   PubMed Web of Science ®Google Scholar
• MasuiHIkeHYamaguchiSMale sexual function after autonomic nerve-preserving operation for rectal cancerDis Colon Rectum199639114011458831531
   PubMed Web of Science ®Google Scholar
• SugiharaKMoriyaYAkasuTFujitaSPelvis autonomic nerve preservation for patients with rectal carcinomaCancer199678187118808909305
   PubMed Web of Science ®Google Scholar
• NastroPBeralDHartleyJMonsonJRTLocal excision of rectal cancer: review of literatureDig Surg20052261515761225
   PubMed Web of Science ®Google Scholar
• MadboulyKMRemziFHErkekBARecurrence after transanal excision of T1 rectal cancer: should we be concerned?Dis Colon Rectum20054871171915768186
   PubMed Web of Science ®Google Scholar
• GuillouPJQuirkePThorpeHShort-term endpoints of conventional versus laparascopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trialLancet20053651718172615894098
   PubMed Web of Science ®Google Scholar
• DeschCEBensonAB3rdSomerfieldMRColorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guidelineJ Clin Oncol2005238512851916260687
   PubMed Web of Science ®Google Scholar
• ComptonCCFieldingLPBurgartLJPrognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999Arch Pathol Lab Med200012497999410888773
   PubMed Web of Science ®Google Scholar
• IacopettaBElsalehHZepsNMicrosatellite instability in colon cancerN Engl J Med20033491774177614593997
   PubMedGoogle Scholar
• RibicCMSargentDJMooreMJTumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerN Engl J Med200334924725712867608
   PubMed Web of Science ®Google Scholar
• BalchGCDeMeoAGuillemJGModern management of rectal cancer: a 2006 updateWorld J Gastroenterol2006123186319516718838
   PubMed Web of Science ®Google Scholar
• TepperJEO’ConnellMNiedzwieckiDAdjuvant therapy in rectal cancer: analysis of stage, sex, and local control-final report of intergroup 0114J Clin Oncol2002201744175011919230
   PubMed Web of Science ®Google Scholar
• SmalleySRBenedettiJKWilliamsonSKPhase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144J Clin Oncol2006243542354716877719
   PubMed Web of Science ®Google Scholar
• O’ConnellMJMartensonJAWieandHSImproving adjuvant therapy for rectal cancer by combining protracted–infusion fluorouracil with radiation therapy after curative surgeryNew Engl J Med19943315025078041415
   PubMed Web of Science ®Google Scholar
• SauerRBeckerHHohenbergerWPreoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med20043511731174015496622
   PubMed Web of Science ®Google Scholar
• RohMSColangeloLWieandSResponse to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum [abstract]J Clin Oncol2004223505
   Web of Science ®Google Scholar
• BensonABCatalanoPJMeropolNJECOG E3201: Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil (FU), leucovorin (LV) (FOLFIRI) vs oxaliplatin, FU/LV (FOLFOX) vs FU/LV for patients (pts) with stage II/III rectal cancer receiving either pre or postoperative radiation (RT)/FU [abstract]J Clin Oncol2006243526
   Web of Science ®Google Scholar
• RyanDPNiedzwieckiDHollisDPhase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901J Clin Oncol2006242557256216636336
   PubMed Web of Science ®Google Scholar
• LandryJRosenthalDSpitzFECOG1297: A phase I study of preoperative radiation therapy (RT) with concurrent protracted continuous infusion 5-FU and dose escalating oxaliplatin followed by surgery, adjuvant 5-FU, and leucovorin for locally advanced (T3/4) rectal adenocarcinomaInt JRadiat Oncol Biol Phys200357S179
   Google Scholar
• RodelCGrabenbauerGGPapadopoulosTPhase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancerJ Clin Oncol2003213098310412915600
   PubMed Web of Science ®Google Scholar
• WillettCGBoucherYdi TomasoEDirect evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNat Med20041014514714745444
   PubMed Web of Science ®Google Scholar
• BirgissonHPahlmanLGunnarssonUGlimeliusBAdverse effects of preoperative radiation therapy for rectal cancer: long term follow up of the Swedish Rectal Cancer TrialJ Clin Oncol2005238697870516314629
   PubMed Web of Science ®Google Scholar
• GundersonLLSargentDJTepperJEImpact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysisJ Clin Oncol2004221785179615067027
   PubMed Web of Science ®Google Scholar
• Sebag-MontefioreDSteeleRQuirkePRoutine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomized trial [abstract]J Clin Oncol200624351116849774
   PubMed Web of Science ®Google Scholar
• QuirkePSebag-MontefioreDSteeleRLocal recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial [abstract]J Clin Oncol2006243512
   Web of Science ®Google Scholar
• RödelCMartusPPapadoupolosTPrognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancerJ Clin Oncol2005238688869616246976
   PubMed Web of Science ®Google Scholar
• KimCAnnePRMichelEImpact of pre-treatment size and lymph nodes on pathological complete response and survival in a prospective trial of chemoradiation [abstract]Int J Radiat Oncol Biol Phys200563Suppl 1641034
   Google Scholar
• Habr-GamaAPerezRONadalinWLong-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survivalJ Gastrointest Surg20059909 discussion, 99–10115623449
   PubMed Web of Science ®Google Scholar
• OnaitisMWNooneRBFieldsRComplete response to neoadjuvant chemoradiation for rectal cancer does not affect survivalAnn Surg Oncol2001880180611776494
   PubMed Web of Science ®Google Scholar
• FuYTLamJCTzeJMMeasurement of irradiated small bowel volume in pelvic irradiation and the effect of a bellyboardClin Oncol (R Coll Radiol)199571881927547523
   PubMedGoogle Scholar
• BollagGMcCormickFRegulators and effectors of ras proteinsAnnu Rev Cell Dev Biol19917601632
   Web of Science ®Google Scholar
• LuiMBryantMSChenJAntitumor activity of SCH66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic miceCancer Res199858494749569810004
   PubMed Web of Science ®Google Scholar
• SkrzatSAngibaudPVenetMR115777, a novel imidazole farnesyl transferase inhibitor (FTI) with potent oral antitumor activityProc Am Soc Cancer Res1998392170a
   Google Scholar
• BrownLFBerseBJackmanRWExpression of vascular permeability factor (vascular endothelial growth factor) and its receptor in adenocarcinomas of the gastrointestinal tractCancer Res199353472747358402650
   PubMed Web of Science ®Google Scholar
• TakahashiYKitadaiYBucanaCDExpression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancerCancer Res199555396439687664263
   PubMed Web of Science ®Google Scholar
• EllisLTakahashiYLiuWVascular endothelial growth factor in human colon cancer: biology and therapeutic implicationsOncologist20005111510804085
   PubMedGoogle Scholar
• VenookANiedzwieckiDHollisDPhase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients with untreated metastatic adenocarcinoma of the colon and rectum: CALGB 80203 preliminary resultsJ Clin Oncol200624suppl 188 abstr 3509148s
   Google Scholar
• GiantonioBJCatalanoPJMeropolNJHigh-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study 3200J Clin Oncol200523suppl 168 abstr 21s15957209
   PubMedGoogle Scholar
• GoldbergRMHurwitzHIFuchsCSThe role of targeted therapy in the treatment of colorectal cancerClin Adv Hematol Oncol200648 Suppl 1711017139241
   PubMedGoogle Scholar
• KabbinavarFFHambletonJMassRDHurwitzHIBergslandESakarSCombined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancerJ Clin Oncol2005233706371215867200
   PubMed Web of Science ®Google Scholar
• SaltzLBRubinMHochsterHCetuximab (IMC-C225) plus irinotecan (CPT-11) is active in CPT-11 refractory colorectal cancer that expresses epidermal growth factor receptorProc Am Soc Clin Oncol2001207a
   Web of Science ®Google Scholar
• O’BrienPCFranklinCIDearKBA phase III double-blind randomized study of rectal sucralfate suspension in the prevention of acute radiation proctitisRadiother Oncol1997451171239424000
   PubMed Web of Science ®Google Scholar
• LeichmanCGDanenbergPVTanMQuantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted infusion fluorouracil and weekly leucovorinJ Clin Oncol199715322332299336359
   PubMed Web of Science ®Google Scholar
• YamachikaTNakanishiHInadaKLA new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significanceCancer19988270779428481
   PubMed Web of Science ®Google Scholar
• LenzHJHayashiKSalongaDP53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancers: an analysis of response and survivalClin Cancer Res19984124312509607583
   PubMed Web of Science ®Google Scholar
• LeggetBYoungJButtenshawRColorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target regionBr J Cancer199571107010737734302
   PubMed Web of Science ®Google Scholar
• LanzaGMatteuzziMGafaRChromosome 18q allelic loss and prognosis in stage II and III colon cancerInt J Cancer1998793903959699532
   PubMed Web of Science ®Google Scholar
• WatanabeTWuTTCatalanoPJMolecular predictors of survival after adjuvant chemotherapy for colon cancerN Engl J Med20013441196120611309634
   PubMed Web of Science ®Google Scholar
• ElsalehHJosephDJLacopettaBMicrosatellite instability is a strong molecular predictive marker for sensitivity to adjuvant chemotherapy in Duke’s C colorectal carcinomaProc Am Soc Clin Oncol200019238a
   Google Scholar
• PalmerDHChenMJKerrDJGene therapy for colorectal cancerBr Med Bull200264202225
   Web of Science ®Google Scholar
• ChenYChangKJHwangLHChenCNTsengSHEstablishment and characterization of a rectal cancer model in mice: application to cytokine gene therapyInt J Colorectal Dis20021738839512355214
   PubMed Web of Science ®Google Scholar
• BensonABIIINew approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage diseaseClin Cancer Res20071322 suppl6913s6918s18006800
   PubMed Web of Science ®Google Scholar
• WatanabeTKomuroYKiyomatsuTPrediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profilesCancer Res2006663370337416585155
   PubMed Web of Science ®Google Scholar
• GhadimiBMGradeMDifilippantonioMJEffectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapyJ Clin Oncol2005231826183815774776
   PubMed Web of Science ®Google Scholar